Trump praised ‘natural 7-OH’; DEA moves to ban it
Two months after President Donald Trump said his administration was looking “very seriously” at approving “natural 7-OH,” the Drug Enforcement Administration moved Wednesday to place the substance into Schedule I as a controlled opioid.
7-OH, or 7-hydroxymitragynine, is a psychoactive compound in the kratom plant, sold in gas stations and smoke shops as tablets, gummies and drink mixes.
The designation would subject anyone who makes, distributes or sells 7-OH above the threshold to the same federal criminal, civil and administrative penalties as heroin or LSD – enforcement DEA would carry out for up to two years under existing agency budget and staffing.
Trump made the comment May 11 in the Oval Office during a maternal health event, telling reporters, “We’re looking very seriously at natural 7-OH and getting that approved.”
The notice of intent DEA filed Wednesday would place 7-OH above a specified threshold into Schedule I, including botanical kratom material, not just synthetic products. The threshold covers kratom exceeding 0.050% 7-OH by dry weight, with no exception for natural products.
“7-OH, MP, MGM-15, and MGM-16 are dangerous opioids that fuel addiction and put American lives at risk,” HHS Secretary Robert F. Kennedy Jr. said in a statement. DEA Administrator Terrance Cole said the action targets “highly concentrated, synthetic 7-OH products.”
DEA filed two notices of intent with the Federal Register Wednesday; both publish July 6. HHS opened a public comment period on the threshold through July 31. DEA can issue a final temporary order 30 days after publication, effective for two years.
DEA cited 165 poison control exposure cases involving 7-OH from January through July 2025, with 35% resulting in serious health problems. Nine states have already banned 7-OH outright; four more cap its concentration.
The action follows FDA warning letters to seven companies selling 7-OH products in July 2025 and a December 2025 seizure of about $1 million worth of 7-OH products from three Missouri firms.
Latest News Stories
Everyday Economics: A stable labor market is not enough
Fishermen advocate begins campaign against offshore wind, ‘industrializing’ of the ocean
Sorensen drug-pricing bill draws criticism from former FDA official
Supporters, critics clash over future of taxpayer funding for Rx Kids
U.S. Senate race headlines Maine primaries as voters head to polls Tuesday
Bessent backs 3% deficit goal despite 5% budget forecasts
Constables hope to find missing children in immigration search effort
Lawmaker blasts reports of ‘equitable assessments’ at medical school
FOID changes advance in Illinois House, not called in Senate
Texas tops California, New York, with the most Fortune 500 headquarters
Nine candidates run in Las Vegas congressional district
U.S. seeks dismissal of lawsuit over deadly boat strikes